Literature DB >> 7308251

Tween 80 increases plasma adriamycin concentrations in mice by an apparent reduction of plasma volume.

S D Harrison, A M Cusic, S M McAfee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308251     DOI: 10.1016/0014-2964(81)90246-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  7 in total

Review 1.  Role of formulation vehicles in taxane pharmacology.

Authors:  L van Zuylen; J Verweij; A Sparreboom
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

Review 2.  Adverse drug events related to dosage forms and delivery systems.

Authors:  I F Uchegbu; A T Florence
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

Review 3.  Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

Authors:  Albert J ten Tije; Jaap Verweij; Walter J Loos; Alex Sparreboom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  Effects of polysorbate 80 on the absorption and distribution of oral methotrexate (MTX) in mice.

Authors:  M N Azmin; J F Stuart; K C Calman; A T Florence
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  The distribution and elimination of methotrexate in mouse blood and brain after concurrent administration of polysorbate 80.

Authors:  M N Azmin; J F Stuart; A T Florence
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Influence of polysorbate 80 (Tween 80) and etoposide (VP-16-213) on the pharmacokinetics and urinary excretion of adriamycin and its metabolites in cancer patients.

Authors:  J Cummings; G J Forrest; D Cunningham; N L Gilchrist; M Soukop
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 7.  Safety of Polysorbate 80 in the Oncology Setting.

Authors:  Lee S Schwartzberg; Rudolph M Navari
Journal:  Adv Ther       Date:  2018-05-23       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.